Compare FARM & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FARM | TXMD |
|---|---|---|
| Founded | 1912 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.3M | 24.3M |
| IPO Year | 1994 | 2012 |
| Metric | FARM | TXMD |
|---|---|---|
| Price | $1.28 | $2.07 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $2.75 | N/A |
| AVG Volume (30 Days) | ★ 191.2K | 16.6K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 73.68 |
| EPS | N/A | ★ 0.01 |
| Revenue | ★ $342,281,000.00 | $1,761,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.57 | N/A |
| P/E Ratio | ★ N/A | $205.00 |
| Revenue Growth | 0.35 | ★ 35.25 |
| 52 Week Low | $1.21 | $0.98 |
| 52 Week High | $2.06 | $2.95 |
| Indicator | FARM | TXMD |
|---|---|---|
| Relative Strength Index (RSI) | 52.14 | 53.35 |
| Support Level | $1.21 | $1.93 |
| Resistance Level | $1.58 | $2.29 |
| Average True Range (ATR) | 0.01 | 0.09 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 75.00 | 76.09 |
Farmer Bros Co is engaged in manufacturing, wholesaling, and distributing coffee, tea, and culinary products to food-service establishments and retailers in the United States. The company's customers include restaurants, hotels, offices, casinos, convenience stores, healthcare facilities, and other food-service providers. The company's product categories include roast and ground coffee, frozen liquid coffee, flavored and unflavored iced and hot teas, culinary products, spices, and other beverages, such as cappuccino, cocoa, granitas, and ready-to-drink iced coffee.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.